Rutaecarpine
AlkaPlorer ID: AK000405
Synonym: None
IUPAC Name: 3,13,21-triazapentacyclo[11.8.0.02,10.04,9.015,20]henicosa-1(21),2(10),4,6,8,15,17,19-octaen-14-one
Structure
SMILES: O=C1C2=CC=CC=C2N=C2C3=C(CCN21)C1=CC=CC=C1N3
InChI: InChI=1S/C18H13N3O/c22-18-13-6-2-4-8-15(13)20-17-16-12(9-10-21(17)18)11-5-1-3-7-14(11)19-16/h1-8,19H,9-10H2
InChIKey: ACVGWSKVRYFWRP-UHFFFAOYSA-N
Reference
Constituents of the Root Wood of <i>Zanthoxylum wutaiense</i> with Antitubercular Activity
PubChem CID: 65752
CAS: 84-26-4
LOTUS: LTS0179404
COCONUT: CNP0352050
data_source: manually
Source
| Species | Genus | Family | Order | Class | Phylum | Kingdom | Domain |
|---|
Properties Information
Molecule Weight: 287.32199999999995
TPSA?: 50.68
MolLogP?: 3.100900000000001
Number of H-Donors: 1
Number of H-Acceptors: 3
RingCount: 5
Activities Information
| Organism | Target Name | Standard Type | Standard Value | Standard Units | doi |
|---|---|---|---|---|---|
| Danio rerio | Danio rerio | IC50 | 25490.0 | nM | None |
| Electrophorus electricus | Acetylcholinesterase | IC50 | 100000.0 | nM | 10.1016/j.ejmech.2009.12.044 |
| Electrophorus electricus | Acetylcholinesterase | IC50 | 100000.0 | nM | 10.1016/j.ejmech.2019.05.055 |
| Electrophorus electricus | Acetylcholinesterase | Inhibition | -4.0 | % | 10.1016/j.bmc.2012.09.040 |
| Equus caballus | Cholinesterase | IC50 | 100000.0 | nM | 10.1016/j.ejmech.2009.12.044 |
| Equus caballus | Cholinesterase | IC50 | 100000.0 | nM | 10.1016/j.ejmech.2019.05.055 |
| Equus caballus | Cholinesterase | Inhibition | -27.56 | % | 10.1016/j.bmc.2012.09.040 |
| Equus caballus | Ferritin light chain | Potency | 39810.7 | nM | None |
| Escherichia coli K-12 | Beta-lactamase AmpC | Potency | 6309.6 | nM | None |
| Homo sapiens | 78 kDa glucose-regulated protein | Potency | 261.2 | nM | None |
| Homo sapiens | A549 | GI50 | 14500.0 | nM | 10.1016/0960-894X(95)00046-V |
| Homo sapiens | A549 | GI50 | 14521.12 | nM | None |
| Homo sapiens | Aldehyde dehydrogenase 1A1 | Potency | 28183.8 | nM | None |
| Homo sapiens | Aldehyde dehydrogenase 1A1 | Potency | 35481.3 | nM | None |
| Homo sapiens | Amyloid-beta A4 protein | Inhibition | 11.25 | % | 10.1016/j.ejmech.2019.05.055 |
| Homo sapiens | Ataxin-2 | Potency | 631.0 | nM | None |
| Homo sapiens | ATPase family AAA domain-containing protein 5 | Potency | 1457.5 | nM | None |
| Homo sapiens | ATPase family AAA domain-containing protein 5 | Potency | 2818.4 | nM | None |
| Homo sapiens | ATPase family AAA domain-containing protein 5 | Potency | 3262.9 | nM | None |
| Homo sapiens | ATPase family AAA domain-containing protein 5 | Potency | 8196.1 | nM | None |
| Homo sapiens | Bloom syndrome protein | Potency | 19952.6 | nM | None |
| Homo sapiens | CAKI-1 | GI50 | 9204.5 | nM | None |
| Homo sapiens | CCD-18Co | IC50 | 50000.0 | nM | 10.1021/acs.jnatprod.2c00224 |
| Homo sapiens | CCD-841CoN | IC50 | 50000.0 | nM | 10.1021/acs.jnatprod.2c00224 |
| Homo sapiens | CCRF-CEM | GI50 | 18879.91 | nM | None |
| Homo sapiens | CCRF-CEM | GI50 | 18900.0 | nM | 10.1016/0960-894X(95)00046-V |
| Homo sapiens | Cellular tumor antigen p53 | Potency | 2511.9 | nM | None |
| Homo sapiens | Cellular tumor antigen p53 | Potency | 12589.3 | nM | None |
| Homo sapiens | Cerebroside-sulfatase | Potency | 21.3 | nM | None |
| Homo sapiens | Chromobox protein homolog 1 | Potency | 79432.8 | nM | None |
| Homo sapiens | COLO 205 | GI50 | 21777.1 | nM | None |
| Homo sapiens | Cyclooxygenase-1 | IC50 | 8700.0 | nM | 10.1016/j.bmc.2012.09.069 |
| Homo sapiens | Cyclooxygenase-1 | IC50 | 8700.0 | nM | 10.1021/np049655u |
| Homo sapiens | Cyclooxygenase-2 | IC50 | 280.0 | nM | 10.1016/j.bmc.2012.09.069 |
| Homo sapiens | Cyclooxygenase-2 | IC50 | 300.0 | nM | 10.1021/np049655u |
| Homo sapiens | Cytochrome P450 1A1 | IC50 | 260.0 | nM | 10.1016/s0960-894x(03)00469-4 |
| Homo sapiens | Cytochrome P450 1A2 | AC50 | 316.23 | nM | None |
| Homo sapiens | Cytochrome P450 1A2 | IC50 | 22.0 | nM | 10.1016/s0960-894x(03)00469-4 |
| Homo sapiens | Cytochrome P450 1B1 | IC50 | 55.0 | nM | 10.1016/j.ejmech.2017.04.042 |
| Homo sapiens | Cytochrome P450 1B1 | IC50 | 55.0 | nM | 10.1016/s0960-894x(03)00469-4 |
| Homo sapiens | Cytochrome P450 2C19 | AC50 | nan | None | None |
| Homo sapiens | Cytochrome P450 2C9 | AC50 | nan | None | None |
| Homo sapiens | Cytochrome P450 2D6 | AC50 | nan | None | None |
| Homo sapiens | Cytochrome P450 3A4 | AC50 | 3981.07 | nM | None |
| Homo sapiens | Cytochrome P450 3A4 | Ki | 107700.0 | nM | 10.2174/138920005774330639 |
| Homo sapiens | Cytochrome P450 3A4 | Kinact | 0.387 | min-1 | 10.2174/138920005774330639 |
| Homo sapiens | Cytochrome P450 3A4 | Potency | 3981.1 | nM | None |
| Homo sapiens | DNA polymerase beta | Potency | 44668.4 | nM | None |
| Homo sapiens | DNA polymerase iota | Potency | 22.4 | nM | None |
| Homo sapiens | DU-145 | GI50 | 17378.01 | nM | None |
| Homo sapiens | EKVX | GI50 | 20653.8 | nM | None |
| Homo sapiens | Endoplasmic reticulum-associated amyloid beta-peptide-binding protein | Potency | 25118.9 | nM | None |
| Homo sapiens | HCT-116 | GI50 | 17538.81 | nM | None |
| Homo sapiens | HCT-116 | IC50 | 31100.0 | nM | 10.1021/acs.jnatprod.2c00224 |
| Homo sapiens | HCT-15 | GI50 | 10000.0 | nM | None |
| Homo sapiens | HCT-15 | IC50 | 50000.0 | nM | 10.1021/acs.jnatprod.2c00224 |
| Homo sapiens | HEK293 | Activity | nan | None | 10.1021/acs.jnatprod.5b00599 |
| Homo sapiens | HEK293 | Potency | 446.7 | nM | None |
| Homo sapiens | HEK293 | Potency | 1834.9 | nM | None |
| Homo sapiens | HeLa | EC50 | 26100.0 | nM | 10.1016/j.bmcl.2017.08.045 |
| Homo sapiens | Histone deacetylase 6 | IC50 | 731.9 | nM | 10.6019/CHEMBL4808148 |
| Homo sapiens | Histone deacetylase 6 | Inhibition | 7.17 | % | 10.6019/CHEMBL4808148 |
| Homo sapiens | Histone deacetylase 6 | Inhibition | 84.3 | % | 10.6019/CHEMBL4808148 |
| Homo sapiens | Histone deacetylase 6 | Inhibition | 99.53 | % | 10.6019/CHEMBL4808148 |
| Homo sapiens | Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 | Potency | 891.3 | nM | None |
| Homo sapiens | Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 | Potency | 1412.5 | nM | None |
| Homo sapiens | HL-60 | GI50 | 24154.61 | nM | None |
| Homo sapiens | HOP-92 | GI50 | 15595.53 | nM | None |
| Homo sapiens | Hs-578T | GI50 | 22600.0 | nM | 10.1016/0960-894X(95)00046-V |
| Homo sapiens | Hs-578T | GI50 | 22646.44 | nM | None |
| Homo sapiens | Huh-7 | Activity | nan | None | 10.1021/jm201328e |
| Homo sapiens | Hypoxia-inducible factor 1 alpha | Potency | 15848.9 | nM | None |
| Homo sapiens | IGROV-1 | GI50 | 19769.7 | nM | None |
| Homo sapiens | K562 | GI50 | 25176.77 | nM | None |
| Homo sapiens | KM12 | GI50 | 10000.0 | nM | None |
| Homo sapiens | LS174T | Activity | 0.5 | % | 10.1021/acs.jnatprod.2c00224 |
| Homo sapiens | LS174T | Activity | 1.3 | % | 10.1021/acs.jnatprod.2c00224 |
| Homo sapiens | LS174T | Activity | 1.4 | % | 10.1021/acs.jnatprod.2c00224 |
| Homo sapiens | LS174T | Activity | 1.5 | % | 10.1021/acs.jnatprod.2c00224 |
| Homo sapiens | LS174T | Activity | 2.1 | % | 10.1021/acs.jnatprod.2c00224 |
| Homo sapiens | LS174T | Activity | 2.2 | % | 10.1021/acs.jnatprod.2c00224 |
| Homo sapiens | LS174T | Activity | 2.4 | % | 10.1021/acs.jnatprod.2c00224 |
| Homo sapiens | LS174T | Activity | 2.7 | % | 10.1021/acs.jnatprod.2c00224 |
| Homo sapiens | LS174T | Activity | 4.1 | % | 10.1021/acs.jnatprod.2c00224 |
| Homo sapiens | LS174T | Activity | 4.4 | % | 10.1021/acs.jnatprod.2c00224 |
| Homo sapiens | LS174T | Activity | 4.5 | % | 10.1021/acs.jnatprod.2c00224 |
| Homo sapiens | LS174T | Activity | 4.7 | % | 10.1021/acs.jnatprod.2c00224 |
| Homo sapiens | LS174T | Activity | 5.6 | % | 10.1021/acs.jnatprod.2c00224 |
| Homo sapiens | LS174T | Activity | 6.1 | % | 10.1021/acs.jnatprod.2c00224 |
| Homo sapiens | LS174T | Activity | 7.0 | % | 10.1021/acs.jnatprod.2c00224 |
| Homo sapiens | LS174T | Activity | 7.2 | % | 10.1021/acs.jnatprod.2c00224 |
| Homo sapiens | LS174T | Activity | 9.6 | % | 10.1021/acs.jnatprod.2c00224 |
| Homo sapiens | LS174T | Activity | 10.7 | % | 10.1021/acs.jnatprod.2c00224 |
| Homo sapiens | LS174T | Activity | 11.8 | % | 10.1021/acs.jnatprod.2c00224 |
| Homo sapiens | LS174T | Activity | 13.9 | % | 10.1021/acs.jnatprod.2c00224 |
| Homo sapiens | LS174T | Activity | 16.8 | % | 10.1021/acs.jnatprod.2c00224 |
| Homo sapiens | LS174T | Activity | 24.7 | % | 10.1021/acs.jnatprod.2c00224 |
| Homo sapiens | LS174T | Activity | 25.9 | % | 10.1021/acs.jnatprod.2c00224 |
| Homo sapiens | LS174T | Activity | 41.5 | % | 10.1021/acs.jnatprod.2c00224 |
| Homo sapiens | LS174T | Activity | 54.6 | % | 10.1021/acs.jnatprod.2c00224 |
| Homo sapiens | LS174T | Activity | 65.7 | % | 10.1021/acs.jnatprod.2c00224 |
| Homo sapiens | LS174T | Activity | 68.3 | % | 10.1021/acs.jnatprod.2c00224 |
| Homo sapiens | LS174T | Activity | 75.8 | % | 10.1021/acs.jnatprod.2c00224 |
| Homo sapiens | LS174T | Activity | 76.9 | % | 10.1021/acs.jnatprod.2c00224 |
| Homo sapiens | LS174T | Activity | 80.3 | % | 10.1021/acs.jnatprod.2c00224 |
| Homo sapiens | LS174T | Activity | 81.6 | % | 10.1021/acs.jnatprod.2c00224 |
| Homo sapiens | LS174T | Activity | 85.4 | % | 10.1021/acs.jnatprod.2c00224 |
| Homo sapiens | LS174T | Activity | 87.3 | % | 10.1021/acs.jnatprod.2c00224 |
| Homo sapiens | LS174T | Activity | 87.4 | % | 10.1021/acs.jnatprod.2c00224 |
| Homo sapiens | LS174T | Activity | 89.5 | % | 10.1021/acs.jnatprod.2c00224 |
| Homo sapiens | LS174T | Activity | nan | None | 10.1021/acs.jnatprod.2c00224 |
| Homo sapiens | LS174T | IC50 | 6100.0 | nM | 10.1021/acs.jnatprod.2c00224 |
| Homo sapiens | LS174T | Inhibition | nan | % | 10.1021/acs.jnatprod.2c00224 |
| Homo sapiens | LXR-beta | IC50 | 67574.0 | nM | None |
| Homo sapiens | Lysine-specific demethylase 4D-like | Potency | 28183.8 | nM | None |
| Homo sapiens | M14 | GI50 | 17100.15 | nM | None |
| Homo sapiens | Malme-3M | GI50 | 28840.32 | nM | None |
| Homo sapiens | Matrix metalloproteinase 9 | IC50 | 7.95 | ug.mL-1 | 10.1016/j.bmcl.2006.09.042 |
| Homo sapiens | MDA-N | GI50 | 15205.48 | nM | None |
| Homo sapiens | MOLT-4 | GI50 | 19860.95 | nM | None |
| Homo sapiens | NCI/ADR-RES | GI50 | 19453.6 | nM | None |
| Homo sapiens | NCI-H23 | GI50 | 17823.79 | nM | None |
| Homo sapiens | Niemann-Pick C1 protein | Potency | 2909.3 | nM | None |
| Homo sapiens | Niemann-Pick C1 protein | Potency | 5623.4 | nM | None |
| Homo sapiens | Nuclear factor erythroid 2-related factor 2 | Potency | 461.1 | nM | None |
| Homo sapiens | Nuclear factor erythroid 2-related factor 2 | Potency | 920.0 | nM | None |
| Homo sapiens | OVCAR-4 | GI50 | 18900.0 | nM | 10.1016/0960-894X(95)00046-V |
| Homo sapiens | OVCAR-4 | GI50 | 18923.44 | nM | None |
| Homo sapiens | OVCAR-5 | GI50 | 17418.07 | nM | None |
| Homo sapiens | OVCAR-8 | GI50 | 26181.83 | nM | None |
| Homo sapiens | Parathyroid hormone receptor | Potency | 17782.8 | nM | None |
| Homo sapiens | PC-3 | GI50 | 22233.1 | nM | None |
| Homo sapiens | Peripheral myelin protein 22 | Potency | 75686.3 | nM | None |
| Homo sapiens | Phosphodiesterase 5A | IC50 | 1230.0 | nM | 10.1016/j.bmcl.2020.127097 |
| Homo sapiens | Prelamin-A/C | Potency | 707.9 | nM | None |
| Homo sapiens | Pyruvate kinase isozymes M1/M2 | Potency | 3162.3 | nM | None |
| Homo sapiens | Ras-related protein Rab-9A | Potency | 1778.3 | nM | None |
| Homo sapiens | Ras-related protein Rab-9A | Potency | 2909.3 | nM | None |
| Homo sapiens | RKO | IC50 | 50000.0 | nM | 10.1021/acs.jnatprod.2c00224 |
| Homo sapiens | RPMI-8226 | GI50 | 15031.42 | nM | None |
| Homo sapiens | RXF 393 | GI50 | 18793.17 | nM | None |
| Homo sapiens | Serine/threonine-protein kinase mTOR | Potency | 18492.7 | nM | None |
| Homo sapiens | Serotonin 1a (5-HT1a) receptor | Ki | 100000.0 | nM | 10.1021/np960678l |
| Homo sapiens | Serum albumin | Ka | 1.0 | uM | 10.1016/j.bmcl.2017.08.045 |
| Homo sapiens | SF-268 | GI50 | 26791.68 | nM | None |
| Homo sapiens | SF-295 | GI50 | 14060.48 | nM | None |
| Homo sapiens | SK-MEL-28 | GI50 | 25176.77 | nM | None |
| Homo sapiens | SK-MEL-5 | GI50 | 14689.26 | nM | None |
| Homo sapiens | SK-OV-3 | GI50 | 19408.86 | nM | None |
| Homo sapiens | SNB-19 | GI50 | 15776.11 | nM | None |
| Homo sapiens | SNB-75 | GI50 | 18879.91 | nM | None |
| Homo sapiens | SR | GI50 | 24434.31 | nM | None |
| Homo sapiens | Survival motor neuron protein | Potency | 7943.3 | nM | None |
| Homo sapiens | SW480 | IC50 | 50000.0 | nM | 10.1021/acs.jnatprod.2c00224 |
| Homo sapiens | SW-620 | GI50 | 18578.04 | nM | None |
| Homo sapiens | T47D | GI50 | 15739.83 | nM | None |
| Homo sapiens | TAR DNA-binding protein 43 | Potency | 3548.1 | nM | None |
| Homo sapiens | Thrombopoietin | Potency | 316.2 | nM | None |
| Homo sapiens | Thyroid stimulating hormone receptor | Potency | 12589.3 | nM | None |
| Homo sapiens | TK-10 | GI50 | 29580.12 | nM | None |
| Homo sapiens | Transient receptor potential cation channel subfamily A member 1 | Activity | nan | None | 10.1021/acs.jnatprod.5b00599 |
| Homo sapiens | Tyrosyl-DNA phosphodiesterase 1 | Potency | 2592.9 | nM | None |
| Homo sapiens | U-251 | GI50 | 15275.66 | nM | None |
| Homo sapiens | UO-31 | GI50 | 14893.61 | nM | None |
| Leishmania major | 2,3-bisphosphoglycerate-independent phosphoglycerate mutase | Potency | 23934.1 | nM | None |
| Mus musculus | Nuclear receptor ROR-gamma | Potency | 12589.3 | nM | None |
| Mus musculus | Nuclear receptor ROR-gamma | Potency | 35481.3 | nM | None |
| Photinus pyralis | Luciferin 4-monooxygenase | Potency | 952.8 | nM | None |
| Plasmodium falciparum | Plasmodium falciparum | IC50 | 10000.0 | nM | 10.1038/nchembio.215 |
| Plasmodium falciparum | Plasmodium falciparum | Potency | 1471.6 | nM | None |
| Plasmodium falciparum | Plasmodium falciparum | Potency | 1651.1 | nM | None |
| Plasmodium falciparum | Plasmodium falciparum | Potency | 6573.3 | nM | None |
| Rattus norvegicus | Aorta | Activity | 72.0 | % | 10.1021/np960161+ |
| Rattus norvegicus | Aorta | Activity | nan | None | 10.1021/np960161+ |
| Rattus norvegicus | Aorta | EC50 | 29.7 | nM | 10.1016/j.ejmech.2019.02.037 |
| Rattus norvegicus | Aorta | EC50 | 156.0 | nM | 10.1016/j.ejmech.2019.02.037 |
| Rattus norvegicus | Aorta | EC50 | 1050.0 | nM | 10.1021/np960161+ |
| Rattus norvegicus | Aorta | EC50 | 1330.0 | nM | 10.1016/j.bmc.2009.02.015 |
| Rattus norvegicus | Aorta | EC50 | 1750.0 | nM | 10.1021/np960161+ |
| Rattus norvegicus | Aorta | Emax | 23.0 | % | 10.1021/np960161+ |
| Rattus norvegicus | Aorta | Emax | 66.3 | % | 10.1016/j.ejmech.2019.02.037 |
| Rattus norvegicus | Aorta | Emax | 75.3 | % | 10.1016/j.ejmech.2019.02.037 |
| Rattus norvegicus | Aorta | Emax | 79.3 | % | 10.1016/j.bmc.2009.02.015 |
| Rattus norvegicus | Aorta | Emax | 96.0 | % | 10.1021/np960161+ |
| Rattus norvegicus | Muscarinic acetylcholine receptor M1 | Potency | 17782.8 | nM | None |
| Rattus norvegicus | Rattus norvegicus | Activity | nan | None | 10.1016/j.ejmech.2019.02.037 |
| Rattus norvegicus | Thioredoxin reductase 1, cytoplasmic | Potency | 28183.8 | nM | None |
| Rattus norvegicus | Thioredoxin reductase 1, cytoplasmic | Potency | 29934.9 | nM | None |
| Rattus norvegicus | Thioredoxin reductase 1, cytoplasmic | Potency | 39810.7 | nM | None |
| Rattus norvegicus | Vanilloid receptor | Activity | -200.3 | pA/pF | 10.1021/acs.jnatprod.5b00599 |
| Rattus norvegicus | Vanilloid receptor | Activity | -157.2 | pA/pF | 10.1021/acs.jnatprod.5b00599 |
| Rattus norvegicus | Vanilloid receptor | Activity | -55.0 | pA/pF | 10.1021/acs.jnatprod.5b00599 |
| Rattus norvegicus | Vanilloid receptor | Activity | 0.0 | mV | 10.1021/acs.jnatprod.5b00599 |
| Rattus norvegicus | Vanilloid receptor | Activity | nan | None | 10.1021/acs.jnatprod.5b00599 |
| Rattus norvegicus | Vanilloid receptor | EC50 | 2060.0 | nM | 10.1021/acs.jnatprod.5b00599 |
| Rattus norvegicus | Vanilloid receptor | Inhibition | nan | % | 10.1021/acs.jnatprod.5b00599 |
| Saccharomyces cerevisiae | Saccharomyces cerevisiae | Potency | 1636.0 | nM | None |
| Severe acute respiratory syndrome coronavirus 2 | Replicase polyprotein 1ab | Inhibition | -0.638 | % | 10.6019/CHEMBL4495564 |
| Severe acute respiratory syndrome coronavirus 2 | SARS-CoV-2 | Inhibition | -4.67 | % | 10.21203/rs.3.rs-23951/v1 |
| Severe acute respiratory syndrome coronavirus 2 | SARS-CoV-2 | Inhibition | -0.1 | % | 10.6019/CHEMBL4495565 |
| Trypanosoma cruzi | Cruzipain | Potency | 39810.7 | nM | None |
| None | ADMET | Activity | nan | None | 10.1021/acs.jnatprod.2c00224 |
| None | ADMET | IC50 | 3.0 | nM | 10.1016/s0960-894x(03)00469-4 |
| None | ADMET | IC50 | 13.0 | nM | 10.1016/s0960-894x(03)00469-4 |
| None | NON-PROTEIN TARGET | Potency | 3.0 | nM | None |
| None | NON-PROTEIN TARGET | Potency | 375.5 | nM | None |
| None | NON-PROTEIN TARGET | Potency | 840.7 | nM | None |
| None | NON-PROTEIN TARGET | Potency | 5951.8 | nM | None |
| None | NON-PROTEIN TARGET | Potency | 12589.3 | nM | None |
| None | NON-PROTEIN TARGET | Potency | 14125.4 | nM | None |
| None | No relevant target | Inhibition | nan | % | 10.1016/j.ejmech.2019.05.055 |
| None | No relevant target | solubility | nan | None | 10.1016/j.bmcl.2017.08.045 |
| None | No relevant target | Solubility | 25.7 | nM | 10.1016/j.bmcl.2017.08.045 |
| None | No relevant target | Solubility | 27.1 | nM | 10.1016/j.bmcl.2017.08.045 |
| None | No relevant target | Solubility | 32.8 | nM | 10.1016/j.bmcl.2017.08.045 |
| None | No relevant target | Solubility | 33.0 | nM | 10.1016/j.bmcl.2017.08.045 |
| None | Nucleic Acid | Activity | 27.6 | uM | 10.1021/jm201328e |
| None | Nucleic Acid | Activity | 1032.98 | None | 10.1021/jm201328e |
| None | Unchecked | AC50 | 25060.0 | nM | None |
| None | Unchecked | AC50 | 195000.0 | nM | None |
| None | Unchecked | Activity | nan | None | 10.1021/acs.jnatprod.2c00224 |
| None | Unchecked | Activity | nan | None | 10.1021/np960161+ |
| None | Unchecked | IC50 | 4300.0 | nM | 10.1021/acs.jnatprod.2c00224 |
| None | Unchecked | IC50 | 67574.0 | nM | None |
| None | Unchecked | Inhibition | nan | % | 10.1021/acs.jnatprod.2c00224 |
| None | Unchecked | Inhibition | nan | % | 10.1038/nchembio873 |
| None | Unchecked | Ka | 1.0 | uM | 10.1016/j.bmcl.2017.08.045 |
| None | Unchecked | Potency | 22.4 | nM | None |
| None | Unchecked | Potency | 446.7 | nM | None |
| None | Unchecked | Potency | 730.8 | nM | None |
| None | Unchecked | Potency | 819.9 | nM | None |
| None | Unchecked | Potency | 1122.0 | nM | None |
| None | Unchecked | Potency | 1157.7 | nM | None |
| None | Unchecked | Potency | 4466.8 | nM | None |
| None | Unchecked | Potency | 5011.9 | nM | None |
| None | Unchecked | Potency | 5804.8 | nM | None |
| None | Unchecked | Potency | 9200.0 | nM | None |
| None | Unchecked | Potency | 10000.0 | nM | None |
| None | Unchecked | Potency | 15848.9 | nM | None |
| None | Unchecked | Potency | 16360.1 | nM | None |
| None | Unchecked | Potency | 19952.6 | nM | None |
| None | Unchecked | Ratio IC50 | nan | None | 10.1016/j.ejmech.2019.05.055 |
